In addition, JNK inhibitor SP600125 prevented the phosphorylation of JNK and the formation of MAP1LC3B-II in PDT-treated CRC cells (Fig. 7C, D). The gene discussed is MAP1LC3B; the disease is colorectal carcinoma.